ENTEGRION, INC.

ENTTEGRION, INC. specializes in applied research and development for defense and biomedical applications, with a focus on advanced plasma-based therapeutics and coagulopathy reversal technologies. Their core capabilities center on designing and executing clinical trials for novel blood product formulations, particularly solvent-detergent spray-dried plasma, to address battlefield trauma and military medical challenges. The company demonstrates deep technical expertise in translational medicine, hemostatic agent development, and clinical trial protocol design for complex biological interventions. Their work integrates principles of biochemistry, pharmaceutical processing, and military medical logistics, distinguishing them through targeted innovation in plasma stabilization and rapid-deployment hemostatic solutions for combat casualty care. The contractor has delivered research services to the Department of Defense, specifically supporting military medical research initiatives focused on improving survival outcomes in hemorrhagic shock. Their engagement reflects a niche alignment with DoD’s Combat Casualty Care and Medical Research & Development programs, where they contribute to evidence-based advancements in battlefield plasma therapeutics. This relationship suggests a pattern of responsive, mission-driven R&D partnerships aimed at closing critical gaps in trauma care capabilities for deployed forces. ENTTEGRION operates primarily within NAICS 541712, which encompasses physical and engineering research excluding biotechnology—indicating a focus on process-driven, non-genetic biomedical innovation. Their market positioning is defined by technical rigor in developing scalable, shelf-stable medical countermeasures for austere environments, serving a specialized segment of defense and federal medical research. They are not engaged in biotech or genomic applications, but rather in physicochemical optimization of plasma-based interventions. As a small business structured as a 2L entity based in Durham, North Carolina, ENTEGRION, INC. maintains a lean, focused operational model. The company holds no federal certifications, and its government market presence is anchored in its technical execution within defense medical R&D rather than broad-scale contracting. Its geographic proximity to research institutions and military medical hubs enhances its capacity to collaborate on high-impact, mission-critical projects.